NYSE:ROL charts & data provided by TradingView

Latest Insights on ROL

October has been a rough month. But the stock market is set to enter its own Tom Brady-like comeback mode, and you don’t want to miss it. The Market Is About to Have a Tom Brady Moment October 30, 2018 by Chad Shoop Stocks October has been a rough month. But the stock market is set to enter its own Tom Brady-like comeback mode, and you don’t want to miss it.
U.S. GDP Is Riddled With Debt October 22, 2018 by Ted Bauman U.S. Economy If you only pay attention to averages, you’ll miss the most important things about the economy. And it’s likely to cost you a lot of money.
Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races. Amarin Stock Soared 570% And Is Maintaining Momentum October 19, 2018 by Joseph Hargett Investment Opportunities Biopharmaceutical companies attract millions of investors. All it takes is one blockbuster drug, and the shares are off to the races.
Platinum Might Soon Be a Great Buy October 15, 2018 by Matt Badiali Investing The market hates metals lately. The prices of things like copper and gold are near two-year lows. However, trade war fears crushed the price of one metal.
President Trump Is Using “the Bank’s Money” to Fight Wars October 15, 2018 by Chad Shoop Government & Politics Trump's comment sheds light on something I have wrote about before — that we are on the cusp of the next major recession for the global economy.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“At the end of August [2018], my 401K was $659,000. Now, on September 4th [2018], it’s $715,000. My account is up $56,000 in the last 5 days!”

- Warren O

“Loving this. Should have started a long time ago.”

- Jay

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

Share This